Peptide Stacking Protocols

Introduction to Peptide Stacking

Stacking means using more than one peptide at a time, usually because users expect the effects to complement each other.

Principles of Effective Stacking

Complementary Mechanisms

• Combine peptides with different actions
• Example: GHRP + GHRH analog for enhanced GH release
• Avoid redundant mechanisms (two GHRPs compete for the same receptor)

Synergistic Effects

• Small IV studies in healthy men: a GHRP plus GHRH released more GH than either alone
• No controlled trial has tested the pairing long term, as users run it

Risk Management

• More compounds = more variables
• Side effects can be additive
• Monitoring becomes more critical

Common Stacking Protocols

GH Release Stack

• Components: GHRP-2 or Ipamorelin + CJC-1295 (no DAC)
• Rationale: GHRP triggers release, GHRH amplifies
• Dosing: Users report 100-300 mcg of each; untested in trials

Recovery Stack

• Components: BPC-157 + TB-500
• Rationale: Complementary healing mechanisms (animal data)
• Application: Injury recovery, joint health (user reports)
• Evidence: BPC-157 emerging, TB-500 preliminary; one uncontrolled 16-patient knee series is the only human data on the pair

Body Composition Stack

• Components: GH secretagogue + Tesamorelin
• Rationale: GH release + fat reduction; tesamorelin is a prescription medicine for HIV-related abdominal fat only
• Considerations: Its label warns of glucose intolerance

Stacking Guidelines

Start Simple

• Community guides begin with one peptide
• A second is added once the response is clear
• Only one new compound at a time

Documentation Essential

• Track each compound separately
• Note timing and dosing
• Record side effects carefully

Sample Stack Protocols

Doses are as community guides report them, not tested protocols.

Beginner Stack (GH Focus)

Advanced Stack

Cautions

• Users describe starting low, then adjusting
• Many guides include off periods between stacks; none are tested

What We Still Don't Know

As of October 2026, no controlled trial has tested these stacks long term, so their combined safety is unknown. Our page on long-term risks by peptide class covers each compound alone.